Navigation Links
Antibiotics in Pregnancy May Shield Newborns From Strep B
Date:1/5/2012

THURSDAY, Jan. 5 (HealthDay News) -- Giving antibiotics to pregnant women at risk of streptococcus B infection greatly reduces infection rates in newborns, according to a new study.

Use of antibiotics to prevent group B strep is common in high-income nations and should also be used in developing countries, at least until a vaccine becomes available, said study author Dr. Karen Edmond, of the London School of Hygiene and Tropical Medicine in England, and colleagues.

The researchers analyzed dozens of previous studies and found that the mean global incidence of group B strep infection in infants up to 3 months old was 0.53 per 1,000 live births and the mean death rate was 10 percent.

Africa had the highest incidence (1.21 cases per 1,000 live births) and death rate (22 percent). Incidence in the Americas [0.67 per 1,000 live births] and Europe [0.57 per 1,000 live births] was also higher than the global average. The death rate was 11 percent in the Americas and 7 percent in Europe.

Worldwide, the death rate for early-onset group B strep infection -- occurring the first week of life -- was 12 percent, twice that of later-onset disease.

Sixty-nine percent of the studies reported use of any preventive antibiotic treatment in the time between labor and delivery (intrapartum). Rates of early-onset disease were three times lower in studies that reported preventive use of antibiotics than those that did not report such use.

The study appears in the Jan. 5 issue of The Lancet.

The most common strep B serotype in all regions was serotype III (49 percent), followed by serotypes Ia (23 percent), Ib (7 percent), II (6 percent), and V (9 percent).

The distribution of strains of strep B appears similar worldwide, which means that vaccines currently in development could have near-universal applicability, according to the researchers.

"A conjugate vaccine incorporating five serotypes (Ia, Ib, II, III, V) could prevent most global group B streptococcal disease," they wrote in a journal news release. Phase 3 trials of vaccines will soon begin in Africa, they said.

"Vaccination of pregnant women also has the potential to reduce premature births, stillbirths, and puerperal sepsis [a toxic condition] caused by group B streptococcus," the researchers said.

More information

The U.S. Centers for Disease Control and Prevention has more about group B strep infections in newborns.

-- Robert Preidt

SOURCE: The Lancet, news release, Jan. 4, 2012


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. More Sore Throats Seen in Acne Patients Taking Antibiotics
2. Preserving lifesaving antibiotics today and for the future
3. Southeast U.S. Still Using High Levels of Antibiotics, Study Shows
4. New method to diagnose sinusitis could reduce use of antibiotics
5. Community storage of anthrax-preventing antibiotics should be determined by state
6. Eye Antibiotics Can Cause Drug-Resistant Bacteria: Study
7. Antibiotics Beat Cranberries at Fighting Urinary Tract Infections in Study
8. Gonorrheas Growing Resistance to Antibiotics Concerns CDC
9. Van Andel Research Institute finding could lead to reduced side effects in anti-cancer antibiotics
10. Docs Overprescribing Antibiotics for Home-Care Patients: Study
11. Too Many Kids Getting Antibiotics for Asthma
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Antibiotics in Pregnancy May Shield Newborns From Strep B
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van ... Wellness at Work award to iHire in recognition of their exemplary accomplishments in worksite ... 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum ...
(Date:6/24/2016)... ... 24, 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. ... the benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has ... , Sickle Cell Disease (SCD) is a disorder of the red blood cells, which ...
(Date:6/24/2016)... San Francisco, CA (PRWEB) , ... June 24, ... ... at CitiDent, is now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has ... , self-ligating Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , ...
(Date:6/24/2016)... ... 24, 2016 , ... EB Medicine presented its first-ever “Issue ... conference in Ponte Vedra Beach, FL. The awards honor the outstanding work of ... and Pediatric Emergency Medicine Practice. , “With this award, we recognize the ...
(Date:6/24/2016)... ... ... National recruitment firm Slone Partners is pleased to announce the ... as Vice President of North American Capital Sales at HTG Molecular . ... team in the commercialization of the HTG EdgeSeq system and associated reagents in North ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Research and Markets has announced the addition of ... report to their offering. ... The World Market for Companion Diagnostics covers the world market ... the report includes the following: , World ... Region (N. America, EU, ROW), 2015-2020 , World IVD ...
(Date:6/23/2016)...  MedSource announced today that it has selected ... of choice.  This latest decision demonstrates MedSource,s commitment ... clients by offering a state-of-the-art electronic data capture ... as the EDC platform of choice in exchange ... has long been a preferred EDC platform by ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced ... BRAHMS PCT (procalcitonin) assay as a dedicated testing solution ... this clearance, Roche is the first IVD company in ... sepsis risk assessment and management. PCT is ... levels in blood can aid clinicians in assessing the ...
Breaking Medicine Technology: